Your browser doesn't support javascript.
loading
Recommendations on the use of item libraries for patient-reported outcome measurement in oncology trials: findings from an international, multidisciplinary working group.
Piccinin, Claire; Basch, Ethan; Bhatnagar, Vishal; Calvert, Melanie; Campbell, Alicyn; Cella, David; Cleeland, Charles S; Coens, Corneel; Darlington, Anne-Sophie; Dueck, Amylou C; Groenvold, Mogens; Herold, Ralf; King-Kallimanis, Bellinda L; Kluetz, Paul G; Kulis, Dagmara; O'Connor, Daniel; Oliver, Kathy; Pe, Madeline; Reeve, Bryce B; Reijneveld, Jaap C; Wang, Xin Shelley; Bottomley, Andrew.
Afiliación
  • Piccinin C; Quality of Life Department, European Organisation for Research and Treatment of Cancer, Brussels, Belgium. Electronic address: claire.piccinin@eort.org.
  • Basch E; Department of Medicine, University of North Carolina, Chapel Hill, NC, USA.
  • Bhatnagar V; Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, MD, USA.
  • Calvert M; Centre for Patient-Reported Outcomes Research, Institute of Applied Health Research, University of Birmingham, Birmingham, UK; Birmingham Health Partners Centre for Regulatory Science and Innovation, University of Birmingham, Birmingham, UK; National Institute for Health and Care Research (NIHR) Bir
  • Campbell A; Digital Health Oncology R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Cella D; Department of Medical Social Sciences, Feinberg School of Medicine, Northwestern University, Evanston, IL, USA.
  • Cleeland CS; Department of Symptom Research, MD Anderson Cancer Center, University of Texas, Houston, TX, USA.
  • Coens C; Quality of Life Department, European Organisation for Research and Treatment of Cancer, Brussels, Belgium.
  • Darlington AS; School of Health Sciences, University of Southampton, Southampton, UK.
  • Dueck AC; Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale, AZ, USA.
  • Groenvold M; Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark; University of Copenhagen, Copenhagen, Denmark.
  • Herold R; European Medicines Agency, Amsterdam, Netherlands.
  • King-Kallimanis BL; LUNGevity Foundation, Chicago, IL, USA.
  • Kluetz PG; Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, MD, USA.
  • Kulis D; Quality of Life Department, European Organisation for Research and Treatment of Cancer, Brussels, Belgium.
  • O'Connor D; Medicines and Healthcare products Regulatory Agency, London, UK.
  • Oliver K; International Brain Tumour Alliance, Tadworth, UK.
  • Pe M; Quality of Life Department, European Organisation for Research and Treatment of Cancer, Brussels, Belgium.
  • Reeve BB; Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, USA.
  • Reijneveld JC; Brain Tumor Center Amsterdam, Amsterdam University Medical Center, Amsterdam, Netherlands.
  • Wang XS; Department of Symptom Research, MD Anderson Cancer Center, University of Texas, Houston, TX, USA.
  • Bottomley A; Quality of Life Department, European Organisation for Research and Treatment of Cancer, Brussels, Belgium.
Lancet Oncol ; 24(2): e86-e95, 2023 02.
Article en En | MEDLINE | ID: mdl-36725153
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Neoplasias Tipo de estudio: Diagnostic_studies / Health_technology_assessment / Prognostic_studies / Qualitative_research Límite: Humans Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Neoplasias Tipo de estudio: Diagnostic_studies / Health_technology_assessment / Prognostic_studies / Qualitative_research Límite: Humans Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article